US Army, USAF intercept cruise missile for 1st time with JLENS-guided AMRAAM
- Multiple Raytheon systems seamlessly integrate to counter cruise missiles
The U.S. Army and U.S. Air Force intercepted for the first time an anti-ship cruise missile surrogate using Raytheon Company's (NYSE: RTN) Advanced Medium Range Air-to-Air Missile (AMRAAM) cued by JLENS. An affordable, elevated, persistent over-the-horizon sensor system, JLENS uses a powerful integrated radar system to detect, track and target a variety of threats.
"Integrating JLENS' precision detection and targeting information with the combat-proven AMRAAM gives our military a new way to defend the fleet and our allies from anti-ship cruise missiles that threaten vital waterways and critical chokepoints," said Dave Gulla, vice president of Global Integrated Sensors for Raytheon's Integrated Defense Systems business.
The Global Missiles and Missile Defense Systems Market 2013-2023 - SWOT Analysis: Market Profile
During the July 17 test, the Army's JLENS acquired and tracked an anti-ship cruise missile surrogate and passed targeting data to an Air Force F-15E via Link 16, enabling the fighter pilot to fire an AIM-120C7 AMRAAM, culminating in the weapon intercepting the target, meeting all test objectives.
"JLENS has proven it can defend and extend the battlespace by integrating with Patriot, Standard Missile-6, and now AMRAAM," said Dean Barten, the U.S. Army's JLENS product manager. "This test enhances the cruise missile defense umbrella, and when this capability is deployed, it will help save lives."
"Integrating AMRAAM with JLENS enables the world's most capable air-to-air missile to engage targets at the weapon's maximum kinematic range," said Harry Schulte, vice president of Raytheon Missile Systems' Air Warfare Systems. "This test further demonstrates AMRAAM's operational flexibility and provides today's warfighter with enhanced operational capability, cost effectiveness and future growth solutions."
Source : Raytheon Corporation (NYSE: RTN)
Jun 24 - 25, 2014 - Washington, United States
Apr 29 - 30, 2014 - London, United Kingdom
Apr 1 - 2, 2014 - Washington, United States